Epic Week: the EHR giant turns AI into an operating system — and the FTC walks in

Epic founder Judy Faulkner used the Aug 18 UGM general session to launch Ergo (Latin for "therefore"), a clinician interface that reassembles itself around the clinical context, due in November 2026. Inside it, Ergo Visit stitches three things into one outpatient flow: ambient charting (Art), the patient-facing assistant (Emmie), and Best Care Choices for My Patient, which queries the Cosmos database for what worked in medically and demographically similar patients (TechTarget). It is live today at Ochsner Health and with five physicians in Epic's Garden Plot programme.

For two years the commercial fight in health AI was "whose scribe is more accurate." Ergo lifts the fight a layer. When the evidence behind a treatment suggestion comes from Epic's own Cosmos — 320 million people and 23 billion encounters — a third-party vendor with a better model still cannot reach the same comparator set. It is a textbook case of a data moat converting directly into a product moat, which is precisely the line the FTC probe is drawn along.

Epic Systems (Verona, Wisconsin; private; founded 1979); early adopter Ochsner Health; Chart with Art now spans 70+ specialties, with its ambient voice layer powered by Microsoft's Dragon platform (On Healthcare Technology).

Agent Factory is Epic's platform for customers to build, deploy and monitor their own AI agents — previewed at HIMSS26, generally available in 2027. Early adopter ECU Health says its transfer-request summarisation agent saves roughly 20 hours a week. Cosmos Curiosity is a generative model trained on Cosmos data that forecasts outcomes such as readmission and stroke, shipping as an embedded EHR component in March 2027. The autonomous coding agent Penny is already live in radiology and emergency medicine and expanding to surgery and pathology.

Revenue cycle is where Epic actually put numbers on the table — and it is exactly the market Commure, R1 and Abridge are chasing: Professional Coding Assistant at 360+ implementations with 40+ groups cutting denials by more than 20%; Denial Appeals Assistant live at 330+ sites, 23% faster appeal drafting; Medical Necessity Insights at 180+ sites, 12,500 hours saved on prior authorisation. Once those are native EHR features, standalone RCM-AI vendors have to prove they are good enough to justify a separate contract.

Epic (Agent Factory, Curiosity, Penny, Emmie, Art, EpicOps); ECU Health and Ochsner Health as early adopters. Epic also announced that Berlin's Charité becomes Germany's first Epic organisation.

Reuters reported exclusively on Aug 14 that the FTC has issued investigative demands to other health-tech firms seeking information on Epic's data-access practices. STAT reported the same day that the probe is early, that at least four people have been contacted, and that it runs along two lines: (1) non-compete and confidentiality agreements restricting staff movement to rivals; (2) whether Epic uses its dominance to block competitors from patient data. An Epic spokesperson said: "We're leaders in interoperability to support patient care, and we do not engage in anticompetitive behavior."

This is not isolated. Texas AG Ken Paxton sued Epic in December over data barriers and fees said to restrict competitors, and records platform Particle Health has its own antitrust suit (Epic is pushing to have it dismissed). Against the UGM backdrop the irony is sharp: Epic is demonstrating the AI advantage Cosmos confers while arguing to regulators that the underlying data advantage was not obtained by excluding rivals. Epic's position is that providers, not Epic, control access to records.

Epic's EHR and MyChart cover more than 280 million U.S. patients, and its research platform spans 310 million (Epic put Cosmos at 320 million at UGM). The FTC declined to comment.

STAT published an investigation into Commure (formerly Athelas) on Aug 12, drawing on interviews with more than three dozen former employees, partners and customers, and reporting that the company "offers thousands of dollars, in various forms, to medical clinics and other parties who refer its products." On Aug 13, STAT reported that Commure emailed notice on Aug 6 terminating the referral programmes with 30 days' notice; chief legal officer Dan Brian said amounts owed as of termination would be paid in full. STAT first asked about the payments in June.

Details compiled by Digital Health Wire include physical-therapy clinics facing a $66,000 "referral obligation fee" if they failed to generate $750,000 in annual referrals, and affiliate partners earning 2% commissions on referred contracts. Former federal prosecutors told STAT that paying for referrals tied to Medicare/Medicaid products can implicate the Anti-Kickback Statute — NextGen Healthcare and athenahealth both settled similar allegations. The warning generalises to the whole "sell AI into clinics" channel model: growth velocity and compliance exposure often ride the same lever.

Founded by Tanay Tandon in 2020, Commure has raised $800 million at a $7 billion valuation and serves 130+ health systems, including HCA Healthcare and Tenet Healthcare (STAT). Customer outcomes are polarised: some report materially better collections, while a Wyoming rehab clinic lost $500k in collections and an Arizona FQHC saw $1 million in denied dental claims it was never told about. Commure calls the practices "industry standard" affecting "a small minority of customers."

Revenue-cycle giant R1 RCM signed a definitive agreement to acquire prior-authorisation automation company Humata Health, expected to close at the end of Q3 2026, terms undisclosed. R1 will fold Humata into its Phare Operating System and move the Humata team into its R37 agentic-AI innovation lab.

Prior authorisation is the most quantifiable slice of U.S. administrative cost: a KFF analysis found insurers denied 12–18% of standard prior-auth requests in 2025 depending on segment. Humata claims a 96% first-pass approval rate, a 30% reduction in write-offs and an 83% drop in rescheduled appointments. Note the timing: the same week, Epic said at UGM that Medical Necessity Insights is live at 180+ sites and has saved 12,500 prior-auth hours — the best exit for an independent vendor is increasingly to be bought by a bigger platform.

On Aug 20, Cityblock Health — which serves urban Medicaid and dual-eligible populations — acquired rural Medicare Advantage provider Homeward Health in an all-stock deal and raised a $116 million Series E led by General Catalyst. The combined company serves nearly 250,000 people.

Cityblock serves nearly 200,000 members on $2.2 billion of annualised revenue (up 77% year over year, and 323% since 2021), having raised more than $900 million; Homeward has served 50,000+ rural patients across 50 counties with 5,000 partner providers. The AI angle: Cityblock's CORE platform uses predictive analytics to flag high-risk members at 62–87% accuracy, and the round is earmarked partly for AI in routine outreach and admin. It is one of the week's few cases where AI is not the product but a cost lever inside value-based care.

STAT reported on Aug 20 that a growing number of health systems are deploying LLM-based tools to query and summarise the chart, Stanford's ChatEHR among them. The anchor case: after six colleagues and 70 stains failed to yield a diagnosis from a lymph node biopsy, a pathologist used ChatEHR to surface that the patient carried a prior diagnosis of sarcomatoid squamous cell carcinoma at another health system, which "completely explained the findings."

This is precisely the capability Epic wants native via Ask Art and Care Everywhere. The contest between academic in-house builds (ChatEHR and its peers) and vendor-native features will decide whether "ask the chart" ends up an open academic capability or a feature locked inside one vendor. STAT also notes these tools require "persistent monitoring."

Per the Fierce Healthcare fundraising tracker (three deals on Aug 18): Happy Health raised a $75M Series A (ARCH Venture Partners, OpenLoop) for continuous home-based care built on an FDA-cleared clinical-grade smart ring, starting with sleep medicine; Hopscotch raised a $53M Series D (led by 8VC and Townhall Ventures) for tech-enabled rural primary care with ambient scribes and AI decision support built in; and Ours Privacy raised a $15M Series A (led by Lightbank and Health Velocity Capital) for HIPAA-compliant cleansing and transmission of marketing data.

What the three share is that none of them position as an "AI company" — AI is an embedded capability, and what is sold is a care model or compliance infrastructure. That is a marked shift from the 2024–25 "AI as the product" narrative, and it comes as digital-health venture funding reached $7.4 billion this year on an AI-powered rebound.